Lionsgate (LION) 10% Owner Mark Rachesky Receives Award Shares

What Happened Dr. Mark H. Rachesky (reported as a 10% owner) received two grants/awards on September 15, 2026 (transaction code A): 6,792 shares at $11.19 each ($76,002) and 13,405 shares at $11.19 each ($150,002), for a combined 20,197 shares valued at approximately $226,004. These were grants/awards from the issuer (not open‑market buys or sales).

Key Details

• Transaction date: 2026-09-15; Filing date (Form 4): 2026-09-17 (filed promptly).
• Grants: 6,792 shares @ $11.19 = $76,002; 13,405 shares @ $11.19 = $150,002; total ≈ $226,004.
• Transaction code: A (grant/award/acquisition).
• Shares owned after transaction: not specified in the provided data.
• Notable footnotes: F1 indicates some shares were issued as director fees; F2 (and other footnotes) indicate restricted share units that vest (e.g., F2 scheduled to vest Sep 15, 2027). Numerous footnotes (F4–F22, F10–F16, etc.) describe that many shares are held through affiliated funds and partnerships and that Dr. Rachesky may be deemed to beneficially own shares held by those entities, but those entities disclaim beneficial ownership except to the extent of pecuniary interest.
• Agreements: footnotes also note certain voting/standstill or governance agreements (F23–F24) that may affect deemed ownership but not pecuniary interest.

Context

• These were issuer grants/awards (not open‑market purchases or sales). Grants and RSUs are often compensation or fee-related and do not by themselves indicate buying or selling intentions.
• As a reported 10% owner, Dr. Rachesky’s holdings are largely held through multiple investment vehicles and fund structures; the filing includes disclaimers that many affiliated entities disclaim beneficial ownership except for pecuniary interest.